Nomifensine treatment of bulimia: Results of an open trial
β Scribed by Crane, Richard A. ;Raskin, Valerie ;Weiler, Martin ;Perri, John ;Jobe, Thomas H. ;Anderson, Jill ;Burg, Bonnie
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1987
- Tongue
- English
- Weight
- 277 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0276-3478
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Seventeen women who met the criteria for bulimia nervosa (DSM-Ill-R) were treated for 4 weeks in an open trial with ipsapirone, a partial 5-HT,\* agonist. Bulimic symptoms diminished in 66.6% of the patients after only 7 week of treatment, 93.3% showed a reduction of more than 50% of weekly binge ea
Patients with the RSH or Smith-Lemli-Opitz syndrome (SLOS) have an inborn error of cholesterol biosynthesis which results in a deficiency of cholesterol and an elevation of the cholesterol precursor, 7-dehydrocholesterol. A treatment protocol consisting of administration of cholesterol Ψ bile acids
Drug resistant depression is a confounding entity. More so in populations of elderly depressives where addition of lithium or antidepressant combinations are possibly hazardous. We present an open-trial of thyroxine in elderly patients diagnosed as suffering from resistant depression. Methods -Thyro